All Stories

  1. Mifepristone alone and in combination with scAAV9-SMN1 gene therapy improves disease phenotypes in Smn2B/- spinal muscular atrophy mice

    Article • Scientific Reports, November 2025, Springer Science + Business Media

    Dr Bernard L Schneider

  2. Gene therapy-mediated overexpression of wild-type MFN2 improves Charcot-Marie-Tooth disease type 2A

    Article • October 2025, openRxiv

    Dr Bernard L Schneider

  3. NATO3 protects dopaminergic neurons in mouse in vivo and human in vitro Parkinson’s disease models

    Article • October 2025, openRxiv

    Dr Bernard L Schneider

  4. One-shot design of functional protein binders with BindCraft

    Article • Nature, August 2025, Springer Science + Business Media

    Dr Bernard L Schneider

  5. Highly frequent undesired insertional mutagenesis during Drosophila genome editing

    Article • August 2025, openRxiv

    Dr Bernard L Schneider

  6. Optogenetic modulation of peripheral nociceptive neurons with biocompatible optoelectronic implants

    Article • Bioengineering & Translational Medicine, June 2025, Wiley

    Dr Bernard L Schneider

  7. Cerebellar dysfunction in frontotemporal dementia: intra-cerebellar pathology and cerebellar network degeneration

    Article • Deutsche Zeitschrift für Nervenheilkunde, March 2025, Springer Science + Business Media

    Dr Bernard L Schneider

  8. Interactions of VMAT2 with CDCrel-1 and Parkin in Methamphetamine Neurotoxicity

    Article • International Journal of Molecular Sciences, December 2024, MDPI AG

    Dr Bernard L Schneider

  9. Liver SMN restoration rescues the Smn mouse model of spinal muscular atrophy

    Article • EBioMedicine, December 2024, Elsevier

    Dr Marc-Olivier Deguise, Dr Bernard L Schneider

  10. TNFα prevents FGF4-mediated rescue of astrocyte dysfunction and reactivity in human ALS models

    Article • Neurobiology of Disease, October 2024, Elsevier

    Dr Bernard L Schneider

  11. Single-cell and spatial atlases of spinal cord injury in the Tabulae Paralytica

    Article • Nature, June 2024, Springer Science + Business Media

    Dr Bernard L Schneider

  12. Production and Purification of Adeno-Associated Viral Vectors (AAVs) Using Orbitally Shaken HEK293 Cells

    Article • January 2024, Springer Science + Business Media

    Dr Bernard L Schneider

  13. Long term peripheral AAV9-SMN gene therapy promotes survival in a mouse model of spinal muscular atrophy

    Article • Human Molecular Genetics, December 2023, Oxford University Press (OUP)

    Dr Bernard L Schneider

  14. TNFα hinders FGF4 efficacy to mitigate ALS astrocyte dysfunction and cGAS-STING pathway-induced innate immune reactivity

    Article • November 2023, openRxiv

    Dr Bernard L Schneider

  15. Differential effect of Fas activation on spinal muscular atrophy motoneuron death and induction of axonal growth

    Article • Cellular and Molecular Biology, October 2023, CMB Association

    Dr Bernard L Schneider

  16. Stable isotope labeling and ultra-high-resolution NanoSIMS imaging reveal alpha-synuclein-induced changes in neuronal metabolism in vivo

    Article • Acta Neuropathologica Communications, September 2023, Springer Science + Business Media

    Dr Bernard L Schneider

  17. Recovery of walking after paralysis by regenerating characterized neurons to their natural target region

    Article • Science, September 2023, American Association for the Advancement of Science

    Dr Bernard L Schneider

  18. AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn 2B/− spinal muscular atrophy mice

    Article • Human Molecular Genetics, July 2023, Oxford University Press (OUP)

    Dr Bernard L Schneider

  19. Mitofusin-2 in nucleus accumbens D2-MSNs regulates social dominance and neuronal function

    Article • Cell Reports, July 2023, Elsevier

    Dr Bernard L Schneider

  20. Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity

    Article • Brain Pathology, November 2022, Wiley

    Dr Bernard L Schneider

  21. Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity

    Article • October 2022, Cold Spring Harbor Laboratory Press

    Dr Bernard L Schneider

  22. Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy

    Article • Gene Therapy, April 2022, Springer Science + Business Media

    Dr Bernard L Schneider, Dr Marc-Olivier Deguise

  23. Astrocyte‐targeting RNA interference against mutated superoxide dismutase 1 induces motoneuron plasticity and protects fast‐fatigable motor units in a mouse model of amyotrophic lateral sclerosis

    Article • Glia, January 2022, Wiley

    Dr Bernard L Schneider

  24. Dopamine and Methamphetamine Differentially Affect Electron Transport Chain Complexes and Parkin in Rat Striatum: New Insight into Methamphetamine Neurotoxicity

    Article • International Journal of Molecular Sciences, December 2021, MDPI AG

    Dr Bernard L Schneider

  25. The exercise-induced long noncoding RNA CYTOR promotes fast-twitch myogenesis in aging

    Article • Science Translational Medicine, December 2021, American Association for the Advancement of Science

    Dr Bernard L Schneider, Jari Lahti

  26. Mitofusin-2 in the Nucleus Accumbens Regulates Anxiety and Depression-like Behaviors Through Mitochondrial and Neuronal Actions

    Article • Biological Psychiatry, June 2021, Elsevier

    Dr Bernard L Schneider

  27. Central anorexigenic actions of bile acids are mediated by TGR5

    Article • Nature Metabolism, May 2021, Springer Science + Business Media

    Dr Bernard L Schneider

  28. Parkin regulates drug-taking behavior in rat model of methamphetamine use disorder

    Article • Translational Psychiatry, May 2021, Springer Science + Business Media

    Dr Bernard L Schneider

  29. The Links between ALS and NF-κB

    Article • International Journal of Molecular Sciences, April 2021, MDPI AG

    Dr Bernard L Schneider

  30. CSPα reduces aggregates and rescues striatal dopamine release in α-synuclein transgenic mice

    Article • Brain, March 2021, Oxford University Press (OUP)

    Dr Bernard L Schneider

  31. Single and Dual Vector Gene Therapy with AAV9-PHP.B Rescues Hearing in Tmc1 Mutant Mice

    Article • Molecular Therapy, March 2021, Elsevier

    Dr Bernard L Schneider

  32. IL10- and IL35-Secreting MutuDC Lines Act in Cooperation to Inhibit Memory T Cell Activation Through LAG-3 Expression

    Article • Frontiers in Immunology, February 2021, Frontiers

    Dr Bernard L Schneider

  33. SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease

    Article • Cellular and Molecular Gastroenterology and Hepatology, January 2021, Elsevier

    Dr Marc-Olivier Deguise, Dr Bernard L Schneider

  34. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology

    Article • Acta Neuropathologica Communications, November 2020, Springer Science + Business Media

    Dr Bernard L Schneider

  35. Efficient viral transduction in mouse inner ear hair cells with utricle injection and AAV9-PHP.B

    Article • Hearing Research, September 2020, Elsevier

    Dr Bernard L Schneider

  36. Nano-imaging trace elements at organelle levels in substantia nigra overexpressing α-synuclein to model Parkinson’s disease

    Article • Communications Biology, July 2020, Springer Science + Business Media

    Dr Bernard L Schneider

  37. Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice

    Article • Movement Disorders, July 2020, Wiley

    Dr Bernard L Schneider

  38. Blood Flow to the Spleen is Altered in a Mouse Model of Spinal Muscular Atrophy

    Article • Journal of Neuromuscular Diseases, April 2020, IOS Press

    Dr Marc-Olivier Deguise, Dr Bernard L Schneider

  39. Glutaredoxin1 Diminishes Amyloid Beta-Mediated Oxidation of F-Actin and Reverses Cognitive Deficits in an Alzheimer's Disease Mouse Model

    Article • Antioxidants & Redox Signaling, December 2019, Mary Ann Liebert Inc

    Dr Bernard L Schneider

  40. Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss

    Article • Nature Reports Stem Cells, July 2019, Springer Science + Business Media

    Dr Bernard L Schneider

  41. Scalable Production of AAV Vectors in Orbitally Shaken HEK293 Cells

    Article • Molecular Therapy — Methods & Clinical Development, June 2019, Elsevier

    Professor Nicole Déglon, Dr Bernard L Schneider

  42. The RNA-Binding Protein PUM2 Impairs Mitochondrial Dynamics and Mitophagy During Aging

    Article • Molecular Cell, February 2019, Elsevier

    Dr Bernard L Schneider

  43. Altered interplay between endoplasmic reticulum and mitochondria in Charcot–Marie–Tooth type 2A neuropathy

    Article • Proceedings of the National Academy of Sciences, January 2019, Proceedings of the National Academy of Sciences

    Dr Bernard L Schneider

  44. Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development

    Article • European Journal of Medical Genetics, November 2018, Elsevier

    Dr Bernard L Schneider

  45. Exogenous LRRK2G2019S induces parkinsonian-like pathology in a nonhuman primate

    Article • JCI Insight, July 2018, American Society for Clinical Investigation

    Dr Bernard L Schneider

  46. PM20D1 is a quantitative trait locus associated with Alzheimer’s disease

    Article • Nature Reports Stem Cells, May 2018, Springer Science + Business Media

    Dr Bernard L Schneider

  47. Cortico–reticulo–spinal circuit reorganization enables functional recovery after severe spinal cord contusion

    Article • Nature Neuroscience, March 2018, Springer Science + Business Media

    Dr Bernard L Schneider

  48. Endoplasmic reticulum and mitochondria in diseases of motor and sensory neurons: a broken relationship?

    Article • Cell Death and Disease, February 2018, Springer Science + Business Media

    Dr Bernard L Schneider

  49. PFN2 and GAMT as common molecular determinants of axonal Charcot-Marie-Tooth disease

    Article • Journal of Neurology Neurosurgery & Psychiatry, February 2018, BMJ

    Dr Bernard L Schneider, Professor Stuart Maudsley

  50. Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis

    Article • Journal of Cerebral Blood Flow & Metabolism, February 2018, SAGE Publications

    Dr Bernard L Schneider

  51. Scalable Production and Purification of Adeno-Associated Viral Vectors (AAV)

    Article • January 2018, Springer Science + Business Media

    Professor Nicole Déglon, Dr Bernard L Schneider

  52. Alpha-synuclein ferrireductase activity is detectible in vivo, is altered in Parkinson's disease and increases the neurotoxicity of DOPAL

    Article • Molecular and Cellular Neuroscience, December 2017, Elsevier

    Dr Bernard L Schneider

  53. Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity

    Article • Molecular Neurodegeneration, November 2017, Springer Science + Business Media

    Dr Bernard L Schneider

  54. In vivo neurochemical measurements in cerebral tissues using a droplet-based monitoring system

    Article • Nature Communications, November 2017, Springer Science + Business Media

    Dr Bernard L Schneider

  55. G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain

    Article • Human Molecular Genetics, October 2017, Oxford University Press (OUP)

    Dr Bernard L Schneider

  56. Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects

    Article • Scientific Reports, October 2017, Springer Science + Business Media

    Dr Bernard L Schneider

  57. An R-CaMP1.07 reporter mouse for cell-type-specific expression of a sensitive red fluorescent calcium indicator

    Article • PLOS One, June 2017, PLOS

    Dr Bernard L Schneider

  58. α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP

    Article • PLOS One, February 2017, PLOS

    Dr Bernard L Schneider

  59. Parkin functionally interacts with PGC-1α to preserve mitochondria and protect dopaminergic neurons

    Article • Human Molecular Genetics, January 2017, Oxford University Press (OUP)

    Dr Bernard L Schneider

  60. Un implant bioactif pour prévenir la maladie d’Alzheimer

    Article • médecine/sciences, January 2017, EDP Sciences

    Dr Bernard L Schneider

  61. Gene Therapy: A Promising Approach for Neuroprotection in Parkinson’s Disease?

    Article • Frontiers in Neuroanatomy, December 2016, Frontiers

    Dr Bernard L Schneider

  62. Axonal Localization of Integrins in the CNS Is Neuronal Type and Age Dependent

    Article • eNeuro, July 2016, Society for Neuroscience

    Dr Bernard L Schneider

  63. Amyloid-β plaque deposition measured using propagation-based X-ray phase contrast CT imaging

    Article • Journal of Synchrotron Radiation, April 2016, International Union of Crystallography

    Dr Bernard L Schneider

  64. A subcutaneous cellular implant for passive immunization against amyloid-β reduces brain amyloid and tau pathologies

    Article • Brain, March 2016, Oxford University Press (OUP)

    Dr Bernard L Schneider

  65. Spinal cord stimulation improves forelimb use in an alpha-synuclein animal model of Parkinson's disease

    Article • International Journal of Neuroscience, February 2016, Informa Healthcare

    Dr Bernard L Schneider

  66. Regulation of Memory Formation by the Transcription Factor XBP1

    Article • Cell Reports, February 2016, Elsevier

    Dr Bernard L Schneider

  67. In Vivo Evidence for a Lactate Gradient from Astrocytes to Neurons

    Article • Cell Metabolism, January 2016, Elsevier

    Dr Bernard L Schneider

  68. Lentiviral Vectors for the Engineering of Implantable Cells Secreting Recombinant Antibodies

    Article • January 2016, Springer Science + Business Media

    Dr Bernard L Schneider

  69. Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease

    Article • Biomolecules, October 2015, MDPI AG

    Dr Bernard L Schneider

  70. Chondroitinase gene therapy improves upper limb function following cervical contusion injury

    Article • Experimental Neurology, September 2015, Elsevier

    Dr Bernard L Schneider

  71. Tmc gene therapy restores auditory function in deaf mice

    Article • Science Translational Medicine, July 2015, American Association for the Advancement of Science

    Dr Bernard L Schneider

  72. Pathway-specific reorganization of projection neurons in somatosensory cortex during learning

    Article • Nature Neuroscience, June 2015, Nature

    Dr Bernard L Schneider

  73. Encapsulated Cellular Implants for Recombinant Protein Delivery and Therapeutic Modulation of the Immune System

    Article • International Journal of Molecular Sciences, May 2015, MDPI AG

    Dr Bernard L Schneider

  74. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease

    Article • Neurobiology of Disease, May 2015, Elsevier

    Dr Bernard L Schneider

  75. PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein

    Article • Acta Neuropathologica Communications, April 2015, Springer Science + Business Media

    Dr Bernard L Schneider

  76. Channel-Mediated Lactate Release by K+-Stimulated Astrocytes

    Article • Journal of Neuroscience, March 2015, Society for Neuroscience

    Dr Bernard L Schneider

  77. Perineuronal net digestion with chondroitinase restores memory in mice with tau pathology

    Article • Experimental Neurology, March 2015, Elsevier

    Dr Bernard L Schneider

  78. SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice

    Article • Annals of Clinical and Translational Neurology, January 2015, Wiley

    Dr Bernard L Schneider

  79. Marinesco-Sjögren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS

    Article • Nature Neuroscience, January 2015, Springer Science + Business Media

    Dr Bernard L Schneider

  80. α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)

    Article • Neurobiology of Disease, January 2015, Elsevier

    Dr Bernard L Schneider

  81. The adipocyte differentiation protein APMAP is an endogenous suppressor of A  production in the brain

    Article • Human Molecular Genetics, September 2014, Oxford University Press (OUP)

    Dr Bernard L Schneider

  82. Overview of Mouse Models of Parkinson's Disease

    Article • Current Protocols in Mouse Biology, September 2014, Wiley

    Dr Bernard L Schneider

  83. Loss of MITF expression during human embryonic stem cell differentiation disrupts retinal pigment epithelium development and optic vesicle cell proliferation

    Article • Human Molecular Genetics, July 2014, Oxford University Press (OUP)

    Dr Bernard L Schneider

  84. A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity

    Article • Human Molecular Genetics, May 2014, Oxford University Press (OUP)

    Dr Bernard L Schneider

  85. Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1

    Article • Proceedings of the National Academy of Sciences, April 2014, Proceedings of the National Academy of Sciences

    Dr Bernard L Schneider

  86. Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration

    Article • Human Molecular Genetics, April 2014, Oxford University Press (OUP)

    Dr Bernard L Schneider

  87. Large-Scale Chondroitin Sulfate Proteoglycan Digestion with Chondroitinase Gene Therapy Leads to Reduced Pathology and Modulates Macrophage Phenotype following Spinal Cord Contusion Injury

    Article • Journal of Neuroscience, April 2014, Society for Neuroscience

    Dr Bernard L Schneider

  88. Intracerebroventricular Injection of Adeno-Associated Virus 6 and 9 Vectors for Cell Type–Specific Transgene Expression in the Spinal Cord

    Article • Human Gene Therapy, February 2014, Mary Ann Liebert Inc

    Dr Bernard L Schneider

  89. A high-capacity cell macroencapsulation system supporting the long-term survival of genetically engineered allogeneic cells

    Article • Biomaterials, January 2014, Elsevier

    Dr Bernard L Schneider

  90. Genetic engineering of cell lines using lentiviral vectors to achieve antibody secretion following encapsulated implantation

    Article • Biomaterials, January 2014, Elsevier

    Dr Bernard L Schneider

  91. Measurement of autophagy flux in the nervous system in vivo

    Article • Cell Death and Disease, November 2013, Springer Science + Business Media

    Dr Bernard L Schneider

  92. FOXO3 determines the accumulation of  -synuclein and controls the fate of dopaminergic neurons in the substantia nigra

    Article • Human Molecular Genetics, October 2013, Oxford University Press (OUP)

    Dr Bernard L Schneider

  93. Application of Viral Vectors to Motor Neuron Disorders

    Article • September 2013, Springer Science + Business Media

    Dr Bernard L Schneider

  94. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity

    Article • Experimental Neurology, September 2013, Elsevier

    Dr Bernard L Schneider

  95. Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo

    Article • Proceedings of the National Academy of Sciences, August 2013, Proceedings of the National Academy of Sciences

    Dr Bernard L Schneider

  96. Behaviour-dependent recruitment of long-range projection neurons in somatosensory cortex

    Article • Nature, June 2013, Springer Science + Business Media

    Dr Bernard L Schneider

  97. Dysregulation of voltage-gated sodium channels by ubiquitin ligase NEDD4-2 in neuropathic pain

    Article • Journal of Clinical Investigation, June 2013, American Society for Clinical Investigation

    Dr Bernard L Schneider

  98. Direct and Retrograde Transduction of Nigral Neurons with AAV6, 8, and 9 and Intraneuronal Persistence of Viral Particles

    Article • Human Gene Therapy, June 2013, Mary Ann Liebert Inc

    Dr Bernard L Schneider

  99. Focal expression of adeno-associated viral-mutant tau induces widespread impairment in an APP mouse model

    Article • Neurobiology of Aging, May 2013, Elsevier

    Dr Bernard L Schneider

  100. Proton and Phosphorus Magnetic Resonance Spectroscopy of a Mouse Model of Alzheimer's Disease

    Article • Journal of Alzheimer’s Disease, September 2012, IOS Press

    Dr Bernard L Schneider

  101. Overexpression of tau in the mouse forebrain using adeno-associated virus (AAV) leads to tau hyperphosphorylation, formation of neurofibrillary tangles and neurodegeneration

    Article • Alzheimer s & Dementia, July 2012, Elsevier

    Dr Bernard L Schneider

  102. Anin vivoultrahigh field 14.1 T1H-MRS study on 6-OHDA and α-synuclein-based rat models of Parkinson's disease: GABA as an early disease marker

    Article • NMR in Biomedicine, June 2012, Wiley

    Dr Bernard L Schneider

  103. Endoplasmic Reticulum Stress Is Important for the Manifestations of  -Synucleinopathy In Vivo

    Article • Journal of Neuroscience, March 2012, Society for Neuroscience

    Dr Bernard L Schneider

  104. Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity

    Article • Acta Neuropathologica, February 2012, Springer Science + Business Media

    Dr Bernard L Schneider

  105.  -Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer

    Article • Journal of Biological Chemistry, February 2012, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Bernard L Schneider

  106. Mimicking Phosphorylation at Serine 87 Inhibits the Aggregation of Human  -Synuclein and Protects against Its Toxicity in a Rat Model of Parkinson's Disease

    Article • Journal of Neuroscience, February 2012, Society for Neuroscience

    Dr Bernard L Schneider

  107. Parkinson's Disease: Gene Therapies

    Article • Cold Spring Harbor Perspectives in Medicine, January 2012, Cold Spring Harbor Laboratory Press

    Dr Bernard L Schneider

  108. Sustained expression of PGC-1  in the rat nigrostriatal system selectively impairs dopaminergic function

    Article • Human Molecular Genetics, January 2012, Oxford University Press (OUP)

    Dr Bernard L Schneider

  109. Lentiviral vectors express chondroitinase ABC in cortical projections and promote sprouting of injured corticospinal axons

    Article • Journal of Neuroscience Methods, September 2011, Elsevier

    Dr Bernard L Schneider

  110. Behavioral and neuropathological characterization of a viral-based model of amyloid pathology

    Article • Alzheimer s & Dementia, July 2011, Elsevier

    Dr Bernard L Schneider

  111. Modelling Alzheimer's disease through Adeno-Associated Virus (AAV) vector gene delivery in the mouse brain

    Article • Alzheimer s & Dementia, July 2011, Elsevier

    Dr Bernard L Schneider

  112. Neuroprotection by Gene Therapy Targeting Mutant SOD1 in Individual Pools of Motor Neurons Does not Translate Into Therapeutic Benefit in fALS Mice

    Article • February 2011, Elsevier

    Dr Bernard L Schneider

  113. A Rat Model of Progressive Nigral Neurodegeneration Induced by the Parkinson's Disease-Associated G2019S Mutation in LRRK2

    Article • Journal of Neuroscience, January 2011, Society for Neuroscience

    Dr Bernard L Schneider

  114. Rab1A Over-Expression Prevents Golgi Apparatus Fragmentation and Partially Corrects Motor Deficits in an Alpha-Synuclein Based Rat Model of Parkinson's Disease

    Article • Journal of Parkinson’s Disease, January 2011, IOS Press

    Dr Bernard L Schneider

  115. Long-range connectivity of mouse primary somatosensory barrel cortex

    Article • European Journal of Neuroscience, June 2010, Wiley

    Dr Bernard L Schneider

  116. Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits  -Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions

    Article • Journal of Neuroscience, March 2010, Society for Neuroscience

    Dr Bernard L Schneider

  117. Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6

    Article • Gene Therapy, September 2009, Springer Science + Business Media

    Dr Bernard L Schneider

  118. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease

    Article • Neurobiology of Disease, July 2009, Elsevier

    Dr Bernard L Schneider

  119. Phosphorylation Does Not Prompt, Nor Prevent, the Formation of  -synuclein Toxic Species in a Rat Model of Parkinson's Disease

    Article • Human Molecular Genetics, December 2008, Oxford University Press (OUP)

    Dr Bernard L Schneider

  120. Regulation of Prenatal Human Retinal Neurosphere Growth and Cell Fate Potential by Retinal Pigment Epithelium and Mash1

    Article • Stem Cells, September 2008, Wiley

    Dr Bernard L Schneider

  121. Viral vectors, animal models and new therapies for Parkinson's disease

    Article • Parkinsonism & Related Disorders, July 2008, Elsevier

    Dr Bernard L Schneider

  122. Systemic AAV6 Delivery Mediating RNA Interference Against SOD1: Neuromuscular Transduction Does Not Alter Disease Progression in fALS Mice

    Article • June 2008, Elsevier

    Dr Bernard L Schneider

  123. Viral Vectors

    Article • January 2008, Elsevier

    Dr Bernard L Schneider

  124. Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy

    Article • Journal of Neuroscience Methods, July 2007, Elsevier

    Dr Bernard L Schneider

  125. Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation

    Article • Human Molecular Genetics, December 2006, Oxford University Press (OUP)

    Dr Bernard L Schneider

  126. Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease

    Article • Neurobiology of Disease, April 2006, Elsevier

    Dr Bernard L Schneider

  127. Inducing Tolerance to a Soluble Foreign Antigen by Encapsulated Cell Transplants

    Article • February 2006, Elsevier

    Dr Bernard L Schneider

  128. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates

    Article • Gene Therapy, December 2005, Springer Science + Business Media

    Dr Bernard L Schneider

  129. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an α-synuclein rat model of Parkinson's disease

    Article • Proceedings of the National Academy of Sciences, December 2004, Proceedings of the National Academy of Sciences

    Dr Bernard L Schneider, Professor Nicole Déglon

  130. Survival of Encapsulated Human Primary Fibroblasts and Erythropoietin Expression Under Xenogeneic Conditions

    Article • Human Gene Therapy, July 2004, Mary Ann Liebert Inc

    Dr Bernard L Schneider, Professor Nicole Déglon

  131. Wlds-Mediated Protection of Dopaminergic Fibers in an Animal Model of Parkinson Disease

    Article • Current Biology, February 2004, Elsevier

    Dr Bernard L Schneider

  132. Wlds-Mediated Protection of Dopaminergic Fibers in an Animal Model of Parkinson Disease

    Article • Current Biology, February 2004, Elsevier

    Dr Bernard L Schneider

  133. Using human neural stem cells to model neurological disease

    Article • Nature Reviews Genetics, February 2004, Springer Science + Business Media

    Dr Bernard L Schneider

  134. Prevention of the initial host immuno-inflammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin delivery

    Article • April 2003, Elsevier

    Dr Bernard L Schneider

  135. Cellular implants: pioneers in xenotransplantation?

    Article • Xenotransplantation, February 2003, Wiley

    Dr Bernard L Schneider

  136. Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia

    Article • Kidney International, October 2002, Elsevier

    Dr Bernard L Schneider, Professor Nicole Déglon

  137. Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia

    Article • Kidney International, October 2002, Elsevier

    Dr Bernard L Schneider, Professor Nicole Déglon

  138. Long-Term Doxycycline-Regulated Secretion of Erythropoietin by Encapsulated Myoblasts

    Article • Molecular Therapy, August 2002, Elsevier

    Dr Bernard L Schneider, Professor Nicole Déglon

  139. α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease

    Article • Proceedings of the National Academy of Sciences, July 2002, Proceedings of the National Academy of Sciences

    Dr Bernard L Schneider, Professor Nicole Déglon

  140. Encapsulation as a Strategy for Cell Xenotransplantation

    Article • May 2002, World Scientific Pub Co Pte Lt

    Dr Bernard L Schneider

  141. INDUCING HOST ACCEPTANCE TO ENCAPSULATED XENOGENEIC MYOBLASTS

    Article • Transplantation, February 2001, Wolters Kluwer Health

    Dr Bernard L Schneider

  142. A self-immunomodulating myoblast cell line for erythropoietin delivery

    Article • Gene Therapy, January 2001, Springer Science + Business Media

    Dr Bernard L Schneider

  143. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts

    Article • Gene Therapy, August 1998, Springer Science + Business Media

    Dr Bernard L Schneider, Professor Nicole Déglon